A team of researchers from Ben-Gurion University of the Negev (BGU) has developed a groundbreaking bio-sensing technology that predicts the response of cancer patients to anti-PD1, an immune checkpoint inhibitor (ICI) therapy, with significantly grea
Since anti-PD1 is the leading immunotherapy treatment in cancer patients, such an achievement can impact the quality of life of thousands of cancer patients worldwide every day.
NEW TREATMENT FOR HEAD AND NECK CANCER isracast.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from isracast.com Daily Mail and Mail on Sunday newspapers.